Author Correction: Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours

Affiliations

• ¹ Clínica Universidad de Navarra, CIMA, IDISNA and CIBERONC, Pamplona, Spain. imelero@unav.es.
• ² Nuffield Department of Medicine, University of Oxford, Oxford, UK. imelero@unav.es.
• ³ START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain.
• ⁴ Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain.
• ⁵ Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain.
• ⁶ Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Spain.
• ⁷ Department of Medical Oncology & Hematology, Cantonal Hospital, St Gallen, Switzerland.
• ⁸ NEXT Oncology Phase I Unit/IOB - Hospital Quirónsalud Barcelona, Barcelona, Spain.
• ⁹ Medizinische Klinik 2, Early Clinical Trial Unit, University Hospital Würzburg, Würzburg, Germany.
• ¹⁰ West German Cancer Center, Department of Medical Oncology, University Hospital Essen, Essen, Germany.
• ¹¹ National Center for Tumor Diseases (NCT) West, Essen, Germany.
• ¹² Department of Medical Oncology, University Hospital Basel, Basel, Switzerland.
• ¹³ Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
• ¹⁴ Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) & Liver Oncology Unit, Liver Unit, Hospital Clínic, Barcelona, Spain.
• ¹⁵ Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.
• ¹⁶ Department of Immunology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain.
• ¹⁷ Department of Gastroenterology, Hepatology and Endocrinology, University Hospital Frankfurt, Frankfurt, Germany.
• ¹⁸ Department of Internal Medicine I, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
• ¹⁹ Institute of Bioinformatics, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
• ²⁰ Department of Urology, Hospital of the Goethe University Frankfurt, Frankfurt am Main, Germany.
• ²¹ Senckenberg Institute of Pathology, University Hospital Frankfurt, Frankfurt am Main, Germany.
• ²² KinDyn Consulting, Warnham, UK.
• ²³ LYO-X AG, Basel, Switzerland.
• ²⁴ The University of Chicago Medical Center, Chicago, IL, USA.
• ²⁵ Centre de Recherche des Cordeliers, INSERM U1138, Sorbonne Université, Université Paris Cité, Paris, France.
• ²⁶ University Medical Center Utrecht and Princess Máxima Center, Utrecht, The Netherlands.
• ²⁷ Comprehensive Cancer Center Munich of the Technical University Munich and the Ludwig-Maximilian University, Munich, Germany.
• ²⁸ Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany.
• ²⁹ Discovery Life Sciences Biomarker Services, Kassel, Germany.
• ³⁰ Metronomia Clinical Research, Munich, Germany.
• ³¹ da Silva Consulting Services, Munich, Germany.
• ³² CatalYm, Munich, Germany.
• ³³ Department of Gynecology, University Hospital Würzburg, Würzburg, Germany.
• ³⁴ CatalYm, Munich, Germany. eugen.leo@catalym.com.